Fintan Walton & Adrian Dawkes, PharmaVentures; Will 2014 be the breakthrough year?




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Fintan Walton & Adrian Dawkes, PharmaVentures; Will 2014 be the breakthrough year?
Released on: January 24, 2014. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this programme Adrian Dawkes talks to Fintan Walton, CEO PharmaVentures, about the recent JP Morgan Healthcare conference and the year ahead for the pharmaceutical and biotec industry.
  • Summary
  • Transcript
  • Participants
  • Company
In this programme Adrian Dawkes talks to Fintan Walton, CEO PharmaVentures, about the recent JP Morgan Healthcare conference and the year ahead for the pharmaceutical and biotec industry. They discuss the challenges for big pharma in the emerging markets and look at the growth in the CRO space in Australia
In this programme Adrian Dawkes talks to Fintan Walton, CEO PharmaVentures, about the recent JP Morgan Healthcare conference and the year ahead for the pharmaceutical and biotec industry. They discuss the challenges for big pharma in the emerging markets and look at the growth in the CRO space in Australia
Fintan Walton & Adrian Dawkes
PharmaVentures
PharmaVentures Ltd
PharmaVentures is a company that has proven success in deals and alliances.

PharmaVentures offers:


• Over 18 years of healthcare industry experience

• Experience gained from working with in excess of 1000 clients in 38 countries, and conducting more than 450 assignments

• Over 40 specialist advisors, analysts and researchers

• Skills honed in many countries - 80% of its business comes from outside the UK